UK GBS Market Analysis


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2572

  • Format: PPT, PDF

UK Guillain-Barre Syndrome Therapeutics Market: Segmented by Diagnosis, Therapeutics, Distribution Channels, and End Users – Growth, Trends, and Forecasts (2020 – 2028)

Published Date: June 2021

SKU: 2572 Categories: ,

Report Overview

The UK Guillain-Barre Syndrome (GBS) therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Guillain-Barre Syndrome is a rare condition concerning the immune system of the body. In Guillain-Barre Syndrome, the body’s immune system starts attacking the body’s own nervous system, resulting in pain and loss of sensation, as well as weakness and pins and needles feeling in the limbs. However, the disease has often been seen to be accompanied by respiratory infections and the stomach flu. Other names for Guillain-Barre syndrome include acute idiopathic polyneuritis, acute idiopathic polyradiculoneuritis, and Landry’s ascending paralysis.

Guillain-Barre Syndrome is rare, affecting one out of every 100,000 people irrespective of gender or age, although it is more common in the 30 to 50 years age group according to a report. Mayo Clinic Healthcare UK specialists have extensive experience with GBS syndrome, treating more than 380 people with Guillain-Barre Syndrome every year. Around nine out of 10 people with Guillain-Barre Syndrome survive and approximately 75 to 90 percent recover completely, while around 10 to 15 percent will be troubled by some form of permanent disability in the future.

Market Growth Drivers

An increasing number of patients with GBS, family history of GBS, strong product pipeline, and increasing financial support to researchers for developing new innovative drugs for the treatment of GBS are likely to drive the GBS market during the forecast period.

Growing awareness about Guillain-Barré syndrome is likely to be a major driver for the Guillain-Barre syndrome market in the UK. The increasing investment into research and development from pharmaceutical companies in the field of discovering cures for rare diseases are likely to be a stimulant for the Guillain-Barre syndrome market over the forecast period

In addition, an increase in special designation from the regulatory authorities to offer treatment to the patients as quickly as possible is enhancing the market. The growing geriatric population is also likely to be a major driver for the Guillain-Barré syndrome market over the forecast period. Immune system disorders are often seen more commonly in the elderly than in younger demographics.


1. UK Guillain-Barre Syndrome Therapeutics Market Overview……………………
A. Market Size
2. Market Growth Drivers………………………………………………………………
A. Huge Financial Support to the Researchers for Developing Novel Intervention
B. High investment into Research and Development
C. Increase in Special Designation from the Regulatory Authorities
D. Increased Burden in Geriatric Population
3. Major Types of Guillain-Barre Syndrome…………………………………………..
A. Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP)
B. Acute Motor Axonal Neuropathy (AMAN)
C. Acute Motor-Sensory Axonal Neuropathy (AMSAN)
D. Miller Fisher Syndrome (MFS)
E. Others
4. Guillain-Barre Syndrome Therapeutics Market Segmentation…………………
A. By Diagnosis
I. Electromyography (EMG)
II. Nerve Conduction Studies
III. Spinal Tap (Lumbar Puncture)
IV. Others
B. By Therapeutics
I. Intravenous Immunoglobulins (IVIG)
II. Plasmapheresis (Plasma Exchange)
III. Pain Killers
IV. Physiotherapy
V. Others
C. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. E- Pharmacies
D. By End Users
I. Academic and Research Organisations
II. Diagnostic Centres
III. Hospitals and Clinics
5. Guillain-Barre Syndrome Major Products Market Share……………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Octapharma Company overview, Product & Services, Strategies & Financials
B. C.S.L. Behring Company overview, Product & Services, Strategies & Financials
C. Grifols Company overview, Product & Services, Strategies & Financials
D. Baxter Company overview, Product & Services, Strategies & Financials
E. Takeda Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of GBS Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Diagnosis:

Based on the diagnosis, the GBS disease therapeutics market is segmented into

  • Electromyography
  • Nerve conduction studies
  • Spinal tap (lumbar puncture)
  • Others

In electromyography, tiny needles are inserted into your muscles and electrical recordings are taken to see how they react when nearby nerves are activated. To conduct the nerve conduction studies, small discs (electrodes) are stuck on your skin and minor electric shocks are used to activate the nerves and measure how quickly these signals travel along with them. While the lumbar puncture is a procedure to remove some fluid from around the spinal cord using a needle inserted into the lower part of the spine and ultimately helps to diagnose Guillain-Barre Syndrome effectively.

By Therapeutics:

Based on therapeutics, the GBS disease therapeutics market is classified into

  • Intravenous immunoglobulin (0.4g/kg daily for 5 days)
  • Plasmapheresis (200-250ml/kg for 5 sessions)
  • Painkillers
  • Physiotherapy
  • Others

The intravenous immunoglobulins (IVIG) are expected to account for the largest share in the UK GBS market which can be attributed to the availability of a wide range of IVIG products and due to the high efficacy of complement inhibitors, and IgG-cleaving enzymes. It also governs by the increased adoption of treatment by off-label use of intravenous immunoglobulins due to the rising prevalence of multifocal motor neuropathy, dermatomyositis, polymyositis, stiff person syndrome, and relapsing-remitting multiple sclerosis. Furthermore, the rise in early approvals for intravenous immunoglobulin (IVIG) products are likely to drive the market during the forecast period.

By Distribution Channel:

In terms of distribution channel, the GBS treatment market can be divided into

  • Hospital pharmacies
  • Retail pharmacies
  • e-pharmacies

The hospital pharmacies segment generated the highest revenue in 2020 and is anticipated to witness growth during the forecast period due to most of the major products are prescription

products, which are available in hospital pharmacies. While the COVID-19 pandemic brightens the future of e-pharmacies too.

By End Users:

As per the end-user, the GBS disease therapeutics market has been segmented into

  • Academic and research organizations
  • Diagnostic centers
  • Hospitals and clinics
  • Others

Mayo Clinic Healthcare UK was among the first centers to develop a neurologic intensive care unit. Each year, Mayo Clinic Healthcare UK specialists evaluate and treat hundreds of people suffering from GBS. Thus, the hospitals and clinics segment commands the largest market share in terms of value during the forecast period.

Top 5 Major Players

The GBS market is highly competitive and major key players operating in UK GBS markets have adopted various strategies to garner high market share. Primarily, the major key players operating in the market are Octapharma UK Ltd., Grifols UK Ltd., CSL Behring UK Ltd., Baxter Healthcare UK Ltd., Takeda Pharmaceuticals UK Ltd. Octagam 5%, Octagam 10%, and Gammanorm are the key products by Octapharma UK Ltd. are used to treat Guillain-Barre Syndrome in the UK market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements